Zambad, S. P., Tuli, D., Mathur, A., Ghalsasi, S. A., Chaudhary, A. R., Deshpande, S., . . . Dutt, C. (2013). TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity. Dove Medical Press.

Zambad, Shitalkumar P., Davinder Tuli, Anoop Mathur, Sameer A. Ghalsasi, Anita R. Chaudhary, Shailesh Deshpande, Ramesh C. Gupta, Vijay Chauthaiwale, ja Chaitanya Dutt. TRC210258, a Novel TGR5 Agonist, Reduces Glycemic and Dyslipidemic Cardiovascular Risk in Animal Models of Diabesity. Dove Medical Press, 2013.

Zambad, Shitalkumar P., et al. TRC210258, a Novel TGR5 Agonist, Reduces Glycemic and Dyslipidemic Cardiovascular Risk in Animal Models of Diabesity. Dove Medical Press, 2013.